HIGHLIGHTS
- who: Marta Baviera from the Laboratory of Prevention, Department of Health Policy, Milan, Italy have published the Article: Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study, in the Journal: (JOURNAL) of December/31,/2019
- what: For instance, in the study by Patorno et_al, patients were considered as in secondary prevention if diagnosed with chronic ischemic heart disease or peripheral artery disease or related procedures, heart failure, ischemic stroke, or lower extremity amputation in the 12 months before inclusion . In the present study, GLP . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.